Company: BSX
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000885725-25-000011
Chunk: 124

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 124
---
IES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) 

Year Ended December 31,(in millions)202420232022Net income (loss)$1,846 $1,592 $698 Other comprehensive income (loss), net of tax:Foreign currency translation adjustment225 (105)(94)Net change in derivative financial instruments1 (115)63 Net change in defined benefit pensions and other items(8)(9)37 Other comprehensive income (loss)218 (230)6 Comprehensive income (loss)2,064 1,362 704 Net income (loss) attributable to noncontrolling interests(8)(1)— Other comprehensive income (loss) attributable to noncontrolling interests(7)(10)— Comprehensive income (loss) attributable to noncontrolling interests(15)(11)— Comprehensive income attributable to Boston Scientific common stockholders$2,079 $1,373 $704 

See notes to the consolidated financial statements. Amounts may not foot due to rounding.

67

BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS As of December 31,(in millions, except share and per share data)20242023ASSETS  Current assets:  Cash and cash equivalents$414 $865 Trade accounts receivable, net2,558 2,228 Inventories2,810 2,484 Prepaid income taxes307 315 Other current assets831 621 Total current assets6,920 6,514 Property, plant and equipment, net3,294 2,859 Goodwill17,089 14,387 Other intangible assets, net6,684 6,003 Deferred tax assets3,655 3,841 Other long-term assets1,754 1,531 TOTAL ASSETS$39,395 $35,136 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current debt obligations$1,778 $531 Accounts payable960 942 Accrued expenses2,773 2,646 Other current liabilities887 814 Total current liabilities6,399 4,933 Long-term debt8,968 8,571 Deferred tax liabilities155 134 Other long-term liabilities1,870 1,967 Commitments and contingenciesStockholders’